Onconetix, Inc. Proceeds from Issuance of Warrants
Onconetix, Inc. (ONCO) reported Proceeds from Issuance of Warrants of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-13
- Onconetix, Inc. proceeds from issuance of warrants for the quarter ending 2022-12-31 was $0.00.
- Onconetix, Inc. proceeds from issuance of warrants for the quarter ending 2022-09-30 was $9.15M.
- Onconetix, Inc. proceeds from issuance of warrants for fiscal 2025 was $0.00.
- Onconetix, Inc. proceeds from issuance of warrants for fiscal 2022 was $16.47M.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 9 month as first filed | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 | |||||||
| 2025-09-22 | $12.90M 10-Q · filed 2025-11-13 | |||||||
| 2024-07-11 | $900.00K 10-K · filed 2026-03-13 | |||||||
| 2023-08-31 | $0.00 10-K · filed 2025-06-02 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | $9.15M derived: sum of 2 quarters · filed 2024-04-11 | $16.47M 10-K · filed 2024-04-11 | $1.44K 10-K · filed 2023-03-09 | ||||
| 2022-09-30 | $9.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $16.47M 10-Q · filed 2023-11-17 | $945.00 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | $7.32M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |